| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +751 | +11% | $0.000000 | 7,324 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $90,402 | -268 | -3.7% | $337.32 | 7,056 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +520 | +7.4% | $0.000000 | 7,576 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $73,536 | -218 | -2.9% | $337.32 | 7,358 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +405 | +5.5% | $0.000000 | 7,763 | 01 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $48,911 | -145 | -1.9% | $337.32 | 7,618 | 01 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +434 | +5.7% | $0.000000 | 8,052 | 02 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $52,285 | -155 | -1.9% | $337.32 | 7,897 | 02 Sep 2024 | Direct | |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Options Exercise | $0 | +557 | +7.1% | $0.000000 | 8,454 | 03 Sep 2024 | Direct | F1 |
| transaction | BIO BIOB | Bio-Rad A Common Stock | Tax liability | $94,610 | -283 | -3.3% | $334.31 | 8,171 | 03 Sep 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -751 | -25% | $0.000000 | 2,254 | 01 Sep 2024 | Bio-Rad A Common Stock | 751 | $0.000000 | Direct | F2, F3 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -520 | -33% | $0.000000 | 1,042 | 01 Sep 2024 | Bio-Rad A Common Stock | 520 | $0.000000 | Direct | F2, F4 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -405 | -50% | $0.000000 | 406 | 01 Sep 2024 | Bio-Rad A Common Stock | 405 | $0.000000 | Direct | F2, F5 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -434 | -100% | $0.000000 | 0 | 02 Sep 2024 | Bio-Rad A Common Stock | 434 | $0.000000 | Direct | F2, F6 |
| transaction | BIO BIOB | Restricted Stock Units | Options Exercise | $0 | -557 | -100% | $0.000000 | 0 | 03 Sep 2024 | Bio-Rad A Common Stock | 557 | $0.000000 | Direct | F2, F7 |
| Id | Content |
|---|---|
| F1 | Shares of Class A common stock acquired on the vesting of restricted stock units. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. |
| F3 | On September 1, 2023, the reporting person was granted 3,005 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F4 | On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F5 | On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F6 | On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| F7 | On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |